Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Ching-yi Chang

Associate Research Professor of Pharmacology and Cancer Biology
Pharmacology & Cancer Biology
Box 103057, Durham, NC 27710
Medical Science Res Bldg III, 3 Genome Court, Durham, NC 27710

Overview


The main focus of my research has been to define the roles of nuclear hormone receptors (NHRs) in the pathogenesis of disease, with a focus on hormone-related cancers. 

During earlier stages of my research career, definition of the structural and molecular determinants of NHR receptor biology and pharmacology was the main focus. Information obtained from these studies was used to guide the development of receptor modulators for therapeutic interventions and to gain insights into the pharmacology of estrogen and androgen receptor ligands. More recently, my research has shifted to define receptor-mediated signaling pathways relevant to the pathogenesis of breast and prostate cancers. One example of this is the definition of signaling pathways downstream of the orphan nuclear receptor, estrogen-related receptor alpha (ERRα) in breast cancer. Using gene expression signature defined in breast cancer cells we demonstrated that the activity of ERRα tracks with poor prognosis in all breast cancer subtypes. We confirmed a causal role for ERRα in breast cancer growth in both cellular and xenograft models of breast cancer. More recently, we further defined the role(s) of this receptor in tumor metabolism and validated its utility as a therapeutic target in triple negative breast cancer (TNBC). In addition to the cancer cell intrinsic effects of ERRα, this receptor is also expressed in T cells and in macrophages. We are currently evaluating the impact of modulating ERRα activity in these immune cells and how that influences tumor biology. 

Current Appointments & Affiliations


Associate Research Professor of Pharmacology and Cancer Biology · 2018 - Present Pharmacology & Cancer Biology, Basic Science Departments

Education, Training & Certifications


University of Cincinnati · 1997 Ph.D.
Tulane University · 1992 M.S.P.H.
China Medical University (China) · 1989 B.S.